This study aimed to compare the bone mineral density (BMD) of patients with ulcerative colitis (UC) and Crohn's disease (CD) in order to determine the possible risk factors for bone loss. A total of 142 patients with UC (n = 88) and CD (n = 54) participated in the study. They were assessed for gender, body mass index (BMI), disease duration and activity, intestinal site of involvement, history of bowel resection, use of steroids, and extra-intestinal findings and complications. The BMD was measured by dual-energy X-ray absorptiometry. There were no differences in BMD between UC and CD patients. In UC patients, BMI showed a significant positive correlation with BMD. Femoral neck Z scores were lower in patients with extra-intestinal findings and complications. Steroid use, disease activity, disease localization, disease duration, bowel surgery and gender had no influence on BMD. Complications or extra-intestinal involvement were a significant predictor for BMD in both groups.
DincaMFriesWLuisettoG: Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol1999; 94: 1292–1297.
2.
BjarnasonIMacphersonAMackintoshC: Reduced bone density in patients with inflammatory bowel disease. Gut1997; 40: 228–233.
3.
CompstonJ: Osteoporosis in inflammatory bowel disease. Gut2003; 52: 63–64.
4.
VestergaardPKroghKRejnmarkL: Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut2000; 46: 176–181.
5.
AbitbolVRouxCChaussadeS: Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology1995; 108: 417–422.
6.
SchoonEJvan NunenABWoutersRS: Osteopenia and osteoporosis in a Dutch population-based cohort. Scand J Gastroenterol Suppl2000; 232: 43–47.
7.
HaderslevKVTjellesenLSorensenHA: Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology2000; 119: 639–646.
8.
ScottEMGaywoodIScott BB, for the British Society of Gastroenterology: Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut2000; 46 (suppl 1): i1–i8.
9.
KanisJA: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporos Int1994; 4: 368–381.
10.
GürlekABayraktarMAriyürekM: Inappropriate reference range for peak bone mineral density in dual-energy X-ray absorptiometry: Implications for the interpretation of T-scores. Osteoporos Int2000; 11: 809–813.
11.
SeoMOkadaMYaoT: An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol1992; 87: 971–976.
12.
HarveyRFBradshawJM: A simple index of Crohn's disease activity. Lancet1980; 315: 514.
13.
BoresLRGarridoJBFurushoJKY: Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol2007; 13: 6156–6165.
14.
FreiPFriedMHungerbühlerV: Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion2006; 73: 40–46.
15.
JahnsenJFalchJAAadlandE: Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study. Gut1997; 40: 313–319.
16.
EdelsteinSLBarrett-ConnorE: Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol1993; 138: 160–169.
17.
FelsonDTZhangYHannanMT: Effects of weight and body mass index on bone mineral density in men and women: The Framingham Study. J Bone Miner Res1993; 8: 567–573.
18.
MartinJPTongeKABhonsleU: Bone mineral density in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol1999; 11: 537–541.
19.
ScharlaSHMinneHWLempertUG: Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol1994; 102: 44–49.
20.
SilvennoinenJAKarttunenTJNiemelaSE: A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut1995; 37: 71–76.
21.
De JongDJCorstensFHMannaertsL: Corticosteroid-induced osteoporosis: Does it occur in patients with Crohn's disease?Am J Gastroenterol2002; 97: 2011–2015.
22.
JahnsenJFalchJAMowinckelP: Bone mineral density in patients with inflammatory bowel disease: A population-based prospective two-year follow-up study. Scand J Gastroenterol2004; 39: 145–153.
23.
ReffittDMMeenanJSandersonJD: Bone density improves with disease remission in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol2003; 15: 1267–1273.
24.
VogelsangHFerenciPWoloszczukW: Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci1989; 34: 1094–1099.
25.
TrommARickelsKHuppeD: Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography. Leber Magen Darm1994; 24: 23–26 [in German].
